Foot And Mouth Disease Vaccine Market
Foot and Mouth Disease (FMD) is infectious disease in domestic animals caused due to viral strain Aphtovirus of the family picornaviridae. It majorly affects cloven hooved livestock such as cattle, goat, sheep, swine, and other animals. It can spread through both direct and indirect modes. Foot and mouth disease causes high morbidity in animals and results into significant economic loss due to decreased milk production, permanent hoof damage, and chronic mastitis. Although adult animals can recover from the disease, mortality is high among young animals, as immunity is not well developed due to which foot and mouth disease vaccination is essential. The disease is characterized by fever and blistery sore on tongue, lips and oral cavity. Foot and mouth disease is best preventable by vaccinating the livestock. There are total seven strains (A, O, C, SAT1, SAT2, SAT3, and Asia1) of the virus that affect animals, symptoms produced are similar in each strain and they can be distinguished only through laboratory tests. Various regions around the world are affected by different set of viral strains. Therefore each strain requires specific vaccine to prevent the infection. Inactivated vaccines are available to prevent animals from being infected by foot and mouth disease.
Market Dynamics
Increasing licensing agreements between government organization and key players are expected to drive market growth of the global foot and mouth disease vaccine market over the forecast period. For instance, in September 2019, Pirbright Institute, a research institute dedicated to the study of infectious diseases of farm animals, and its research partners had granted MSD Animal Health, the organizational company that offers innovative veterinary pharmaceuticals and vaccines services, an exclusive commercial licence for a new, effective, and affordable vaccine to protect livestock against several serotypes of foot-and-mouth disease virus. The vaccine has been developed from basic science to animal trials as a result of long-standing collaborations between Pirbright, the University of Oxford, Diamond Light Source, the University of Reading, and MSD Animal Health, a division of Merck & Co., Inc., who will be taken in 2022 forward the new technology into development, registration and manufacturing.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 35 market data tables and 30 figures on "Global Foot and Mouth Disease Vaccine Market” - forecast to 2030
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients